Publications

• How I treat ETP-ALL in children.
  Blood Volume: 145 Page(s): 43 - 52
  01/02/2025 Authors: Summers RJ; Teachey DT; Hunger SP
• SNPing away poor outcomes in T-ALL.
  Blood Volume: 144 Page(s): 924 - 925
  08/29/2024 Authors: Summers RJ; Teachey DT
• Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
  Blood Volume: 142 Page(s): 2069 - 2078
  12/14/2023 Authors: Wood BL; Devidas M; Summers RJ; Chen Z; Asselin B; Rabin KR; Zweidler-McKay PA; Winick NJ; Borowitz MJ; Carroll WL
• High burden of clinically significant adverse events associated with contemporary therapy for pediatric T-cell acute lymphoblastic leukemia/lymphoma.
  Pediatr Blood Cancer Volume: 70 Page(s): e30571
  11/01/2023 Authors: Summers RJ; Monroig VM; DeGroote NP; West ZE; Katafias E; Miller TP
• Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia.
  Nat Commun Volume: 14 Page(s): 6209
  10/05/2023 Authors: Mumme H; Thomas BE; Bhasin SS; Krishnan U; Dwivedi B; Perumalla P; Sarkar D; Ulukaya GB; Sabnis HS; Park SI
• Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML.
  Pharm Res Volume: 40 Page(s): 2133 - 2146
  09/01/2023 Authors: Kelvin JM; Jain J; Thapa A; Qui M; Birnbaum LA; Moore SG; Zecca H; Summers RJ; Switchenko JM; Costanza E
• Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis.
  Sci Rep Volume: 13 Page(s): 12556
  08/02/2023 Authors: Bhasin SS; Thomas BE; Summers RJ; Sarkar D; Mumme H; Pilcher W; Emam M; Raikar SS; Park SI; Castellino SM
• RESPONSE TO REINDUCTION CHEMOTHERAPY IN FIRST RELAPSE PEDIATRIC B-ALL: A SINGLE-INSTITUTION REVIEW
  Volume: 70 Page(s): S49 - S50
  06/01/2023 Authors: Digiandomenico S; Summers R; Bennett A; Sabnis H; Aumann W
• Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML.
  bioRxiv
  03/15/2023 Authors: Kelvin JM; Jain J; Thapa A; Qui M; Birnbaum LA; Moore SG; Zecca H; Summers RJ; Costanza E; Uricoli B
• Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia.
  Cancers (Basel) Volume: 14
  12/13/2022 Authors: Summers RJ; Jain J; Vasileiadi E; Smith B; Chimenti ML; Yeung TY; Kelvin J; Wang X; Frye SV; Earp HS
• SOHO State of the Art Updates and Next Questions | Novel Approaches to Pediatric T-cell ALL and T-Lymphoblastic Lymphoma.
  Clin Lymphoma Myeloma Leuk Volume: 22 Page(s): 718 - 725
  10/01/2022 Authors: Summers RJ; Teachey DT
• SIGNIFICANT BURDEN OF ADVERSE EVENTS DURING THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
  Volume: 69
  06/01/2022 Authors: Summers R; Monroig V; DeGroote N; West Z; Katafias E; Castellino S; Miller T
• Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.
  JCO Precis Oncol Volume: 6 Page(s): e2100451
  04/01/2022 Authors: Summers RJ; Castellino SM; Porter CC; MacDonald TJ; Basu GD; Szelinger S; Bhasin MK; Cash T; Carter AB; Castellino RC
• Single Cell Transcriptomics Revealed AML and Non-AML Cell Clusters Relevant to Relapse and Remission in Pediatric AML
  Volume: 136
  11/05/2020 Authors: Thomas BE; Perumalla P; Bhasin SS; Sarkar D; Dwivedi B; Park SI; DeRyckere D; Henry CJ; Raikar SS; Porter CC
• NEXT-GENERATION SEQUENCING REVEALS INCREASED PREVALENCE OF PICALM-MLLT10 FUSIONS IN T-ALL AND T-LLY
  Volume: 67 Page(s): S167 - S167
  06/01/2020 Authors: Summers R; Aumann W; Pauly M; Goldsmith K; Porter C; Worsley R; Graham D; Castellino S; Wechsler D
• MERTK and BCL-2 as potential therapeutic targets in early T-precursor acute lymphoblastic leukemia
  Volume: 79
  07/01/2019 Authors: Summers RJ; Minson KA; Vasileiadi E; Wang X; Frye SV; Earp HS; DeRyckere D; Graham DK
• MERTK and BCL-2 as potential therapeutic targets in early T-precursor acute lymphoblastic leukemia
  Volume: 78
  10/01/2018 Authors: Summers RJ; Minson KA; Wang X; Frye SV; Earp HS; DeRyckere D; Graham DK
• Comment on: Value of flow cytometric analysis of peripheral blood samples in children diagnosed with acute lymphoblastic leukemia.
  Pediatr Blood Cancer Volume: 65
  10/08/2017 Authors: Summers RJ; Metrock LK; Park S; Gillespie S; Castellino S; Lew G; Keller FG
• Utility of peripheral blood immunophenotyping by flow cytometry in the diagnosis of pediatric acute leukemia.
  Pediatr Blood Cancer Volume: 64
  10/01/2017 Authors: Metrock LK; Summers RJ; Park S; Gillespie S; Castellino S; Lew G; Keller FG
• MERTK is a Potential Therapeutic Target in Early Thymic Precursor Acute Lymphoblastic Leukemia
  Volume: 64 Page(s): S3 - S3
  06/01/2017 Authors: Summers R; Minson K; Wang X; Frye S; Earp HS; DeRyckere D; Graham D
• Methicillin-resistant Staphylococcus aureus empyema Necessitatis in a breast-fed neonate.
  Pediatr Infect Dis J Volume: 33 Page(s): 668 - 669
  06/01/2014 Authors: Rosebush J; Summers R; Snitzer J; Jerris R; Satola S; Spearman P
• UTILITY OF PERIPHERAL BLOOD IMMUNOPHENOTYPING BY FLOW CYTOMETRY IN THE DIAGNOSIS OF PEDIATRIC LEUKEMIA
  Volume: 61 Page(s): S84 - S84
  05/01/2014 Authors: Summers R; Williamson L; Gillespie S; Park S; Lew G; Keller F
• Correlating pathology with the clinical symptoms of methotrexate-induced leukoencephalopathy in a child with relapsed T-cell acute lymphoblastic leukemia.
  J Pediatr Hematol Oncol Volume: 36 Page(s): e19 - e22
  01/01/2014 Authors: Summers RJ; Abramowsky CR; Cooper TM
• Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional protein.
  Blood Volume: 117 Page(s): 3190 - 3198
  03/17/2011 Authors: Summers RJ; Meeks SL; Healey JF; Brown HC; Parker ET; Kempton CL; Doering CB; Lollar P
• N1922S Mutation In the Factor VIII A3 Domain Produces a Rate-Limiting, Domain-Specific Folding Defect Leading to Hyposecretion of a Functional Protein.
  Volume: 116 Page(s): 910 - 910
  11/19/2010 Authors: Summers RJ; Meeks SL; Healey JF; Brown HC; Parker ET; Doering C; Kempton CL; Lollar JPS
• Mucinous adenocarcinoma of the lung in association with congenital pulmonary airway malformation.
  J Pediatr Surg Volume: 45 Page(s): 2256 - 2259
  11/01/2010 Authors: Summers RJ; Shehata BM; Bleacher JC; Stockwell C; Rapkin L
• Cleft palate is caused by CNS dysfunction in Gad1 and Viaat knockout mice.
  PLoS One Volume: 5 Page(s): e9758
  03/19/2010 Authors: Oh W-J; Westmoreland JJ; Summers R; Condie BG